Advances in targeted therapies VIII F C Breedveld, J R Kalden, and J S Smolen Ann Rheum Dis 2006; 65 (Supplement 3 ): iii1. doi:10.1136/ard.2006.058610 [Extract] [Full text] [PDF] [Request Permissions]
	Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006 D E Furst, F C Breedveld, J R Kalden, J S Smolen, G R Burmester, P Emery, E C Keystone, M H Schiff, P L C M van Riel, M E Weinblatt, and M H Weisman Ann Rheum Dis 2006; 65 (Supplement 3 ): iii2-iii15. doi:10.1136/ard.2006.061937 [Extract] [Full text] [PDF] [Request Permissions]
	More relevant, precise, and efficient items for assessment of physical function and disability: moving beyond the classic instruments J F Fries, B Bruce, J Bjorner, and M Rose Ann Rheum Dis 2006; 65 (Supplement 3 ): iii16-iii21. doi:10.1136/ard.2006.059279 [Abstract] [Full text] [PDF] [Request Permissions]
	Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases? D D Gladman Ann Rheum Dis 2006; 65 (Supplement 3 ): iii22-iii24. doi:10.1136/ard.2006.058453 [Extract] [Full text] [PDF] [Request Permissions]
	Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different? M M Ward Ann Rheum Dis 2006; 65 (Supplement 3 ): iii25-iii28. doi:10.1136/ard.2006.058461 [Abstract] [Full text] [PDF] [Request Permissions]
	Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis M I Koenders, L A B Joosten, and W B van den Berg Ann Rheum Dis 2006; 65 (Supplement 3 ): iii29-iii33. doi:10.1136/ard.2006.058529 [Abstract] [Full text] [PDF] [Request Permissions]
	The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity M P Cancro Ann Rheum Dis 2006; 65 (Supplement 3 ): iii34-iii36. doi:10.1136/ard.2006.058412 [Abstract] [Full text] [PDF] [Request Permissions]
	Role of nitric oxide in the regulation of T cell functions W Niedbala, B Cai, and F Y Liew Ann Rheum Dis 2006; 65 (Supplement 3 ): iii37-iii40. doi:10.1136/ard.2006.058446 [Abstract] [Full text] [PDF] [Request Permissions]
	Can studies of tolerance ever lead to therapy? H von Boehmer Ann Rheum Dis 2006; 65 (Supplement 3 ): iii41-iii43. doi:10.1136/ard.2006.058396 [Abstract] [Full text] [PDF] [Request Permissions]
	Pharmacoeconomics: friend or foe? M Drummond Ann Rheum Dis 2006; 65 (Supplement 3 ): iii44-iii47. doi:10.1136/ard.2006.058602 [Abstract] [Full text] [PDF] [Request Permissions]
	Natalizumab and progressive multifocal leucoencephalopathy J R Berger Ann Rheum Dis 2006; 65 (Supplement 3 ): iii48-iii53. doi:10.1136/ard.2006.058404 [Abstract] [Full text] [PDF] [Request Permissions]
	Serious infections with antirheumatic therapy: are biologicals worse? K L Winthrop Ann Rheum Dis 2006; 65 (Supplement 3 ): iii54-iii57. doi:10.1136/ard.2006.058503 [Abstract] [Full text] [PDF] [Request Permissions]
	Treating rheumatic diseases in pregnancy: dos and don’ts M D Lockshin Ann Rheum Dis 2006; 65 (Supplement 3 ): iii58-iii60. doi:10.1136/ard.2006.058420 [Abstract] [Full text] [PDF] [Request Permissions]
	IL-32, a novel cytokine with a possible role in disease C A Dinarello and S-H Kim Ann Rheum Dis 2006; 65 (Supplement 3 ): iii61-iii64. doi:10.1136/ard.2006.058511 [Abstract] [Full text] [PDF] [Request Permissions]
	Heat shock proteins induce T cell regulation of chronic inflammation F Hauet-Broere, L Wieten, T Guichelaar, S Berlo, R van der Zee, and W Van Eden Ann Rheum Dis 2006; 65 (Supplement 3 ): iii65-iii68. doi:10.1136/ard.2006.058495 [Abstract] [Full text] [PDF] [Request Permissions]
	Interleukin-7 induced immunopathology in arthritis S A Y Hartgring, J W J Bijlsma, F P J G Lafeber, and J A G van Roon Ann Rheum Dis 2006; 65 (Supplement 3 ): iii69-iii74. doi:10.1136/ard.2006.058479 [Abstract] [Full text] [PDF] [Request Permissions]
	Use of cell permeable NBD peptides for suppression of inflammation I Strickland and S Ghosh Ann Rheum Dis 2006; 65 (Supplement 3 ): iii75-iii82. doi:10.1136/ard.2006.058438 [Abstract] [Full text] [PDF] [Request Permissions]
	Mitogen activated protein kinase inhibitors: where are we now and where are we going? S E Sweeney and G S Firestein Ann Rheum Dis 2006; 65 (Supplement 3 ): iii83-iii88. doi:10.1136/ard.2006.058388 [Abstract] [Full text] [PDF] [Request Permissions]
	Targeted therapies: summary clinical trials working group M E Weinblatt and P L C M van Riel Ann Rheum Dis 2006; 65 (Supplement 3 ): iii89. doi:10.1136/ard.2006.060939 [Extract] [Full text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.